Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials


Shahbar, A.; Alawlqi, A.; Alhifany, A.; Noor, A.; Almutairi, A.R.; Alnuhait, M.
Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials. J. Clin. Med. 2025, 14, 1811.
https://doi.org/10.3390/jcm14061811

AMA Style

Shahbar A, Alawlqi A, Alhifany A, Noor A, Almutairi AR, Alnuhait M.
Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials. Journal of Clinical Medicine. 2025; 14(6):1811.
https://doi.org/10.3390/jcm14061811

Chicago/Turabian Style

Shahbar, Alaa, Abdulaziz Alawlqi, Abdullah Alhifany, Afnan Noor, Abdulaali R. Almutairi, and Mohammed Alnuhait.
2025. “Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials” Journal of Clinical Medicine 14, no. 6: 1811.
https://doi.org/10.3390/jcm14061811

APA Style

Shahbar, A., Alawlqi, A., Alhifany, A., Noor, A., Almutairi, A. R., & Alnuhait, M.

(2025). Safety and Efficacy of Direct Oral Anticoagulants Apixaban and Rivaroxaban Versus Standard Therapy for VTE Prophylaxis Post Cancer Surgery—A Network Meta-Analysis of Randomized Clinical Trials. Journal of Clinical Medicine, 14(6), 1811.
https://doi.org/10.3390/jcm14061811



Source link

Alaa Shahbar www.mdpi.com